Medgenics, Inc. (AMEX: MDGN)

MDGN previously reported that the Company received notice of ?Intention to Grant' from the European Patent Office for the patent application entitled ?USE OF DERMAL MICRO ORGANS,? with allowed claims covering a core element of its Biopump? protein therapy technology.